Skip to main content

Cardiovascular Death

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Biosensors International
Biosensors InternationalSingapore - Singapore
1 program
BioFreedom BA9N/A1 trial
Active Trials
NCT05331547Unknown50Est. Jan 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Biosensors InternationalBioFreedom BA9

Clinical Trials (1)

Total enrollment: 50 patients across 1 trials

NCT05331547Biosensors InternationalBioFreedom BA9

BioFreedom™ BA9™ Ultra

Start: Jul 2021Est. completion: Jan 202450 patients
N/AUnknown

Related Jobs

Director, Global Regulatory Strategist -Allergy/Cardiovascular Portfolio

Viatris (2)Viatris (2)
Washington, District of Columbia, USA
3mo ago
$112K - $236K/yr

Director, Global Regulatory Strategist -Allergy/Cardiovascular portfolio

Viatris (2)Viatris (2)
Northern Cross, Dublin, Ireland
4mo ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.